P50 Apolipoprotein E and low-density, apolipoprotein B associated lipoviral particles in chronic hepatitis C infection: evidence for genotype-specific modulation of lipid pathwaysBridge, S.; Sheridan, D.; Felmlee, D.; Crossey, M.; Thomas, H.; Taylor-Robinson, S.; Toms, G.; Neely, D.; Bassendine, M. · Gut · 2011

PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: Evidence for genotype-specific regulation of lipoprotein metabolismBridge, Simon H.; Sheridan, David A.; Felmlee, Daniel J.; Crossey, Mary M.E.; Fenwick, Fiona I.; Lanyon, Clare V.; Dubuc, Geneviève; Seidah, Nabil G.; Davignon, Jean; Thomas, Howard C.; Taylor-Robinson, Simon D.; Toms, Geoffrey L.; Neely, R. Dermot G.; Bassendine, Margaret F. · Journal of Hepatology · 2015

1183 THE “INTERFERON PARADOX” AS A PREDICTOR OF NON-RESPONSE TO ANTI-VIRAL THERAPY: NOVEL ASSOCIATION WITH APOLIPOPROTEIN E AND HEPATITIS C VIRUS (HCV) LIPOVIRAL PARTICLES (LVP)Sheridan, P.; Bridge, S.; Felmlee, D.; Taylor Robinson, S.; Thomas, H.; Toms, G.; Neely, D.; Bassendine, M. · Journal of Hepatology · 2011